US 10463744
Polymer-semaxanib moiety conjugates
granted A61KA61K31/404A61K47/545
Quick answer
US patent 10463744 (Polymer-semaxanib moiety conjugates) held by Nektar Therapeutics expires Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Nektar Therapeutics
- Grant date
- Tue Nov 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/404, A61K47/545, A61K47/60, A61P